Stay updated on ALLO-501A & ALLO-647 Lymphodepletion Clinical Trial
Sign up to get notified when there's something new on the ALLO-501A & ALLO-647 Lymphodepletion Clinical Trial page.

Latest updates to the ALLO-501A & ALLO-647 Lymphodepletion Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new version entry (v3.4.2) was added to the history, and the funding-status notice was removed. These are site maintenance updates that do not alter study data or record content.SummaryDifference0.7%

- Check21 days agoChange DetectedThe page history shows a new revision entry (v3.4.1) and the removal of v3.4.0, plus a site-wide notice about government funding. These are metadata changes rather than core trial content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check28 days agoChange DetectedThe history page now includes a glossary toggle and color-coded indicators for additions and deletions with explanatory text. Footer revision notes were updated to v3.4.0 and the No FEAR Act labeling was altered; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check42 days agoChange DetectedAdded revision v3.3.4 to the history; the prior revision v3.3.3 was removed from the history display.SummaryDifference0.1%

- Check49 days agoChange DetectedVersion 13 (2025-12-11) shows termination for business reasons and the posting of results, including Outcome Measures (Results) and Baseline Characteristics. These updates reflect a change in study status and the availability of results data.SummaryDifference0.9%

- Check64 days agoChange DetectedThe latest revision adds Revision: v3.3.3 to the history and removes HHS Vulnerability Disclosure and the older Revision: v3.3.2 from the footer; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to ALLO-501A & ALLO-647 Lymphodepletion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALLO-501A & ALLO-647 Lymphodepletion Clinical Trial page.